Published: Oct, 2016
The leading players in the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests, raked in a lion's share of 96% in the overall market in 2014. The key players, Hologic, Inc., F. Hoffmann-La Roche Ltd., Nanosphere, and MeridianBioscience, Inc. held dominating shares due to an excellent brand equity and strong geographical presence. “Widening their product portfolio will prove to be a lucrative growth opportunity for the players in the market,” states the leading author of this research report.
Quick Turnaround Time Makes iNAT a Preferred Choice
According to the research report, the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests is expected to be worth US$22.3 mn by the end of 2023 from US$8.3 mn in 2014. Analysts predict that the market will expand at CAGR of 11.6% between 2015 and 2023. The report states that the isothermal nucleic acid amplification technology (iNAT) is expected to surge at a steady CAGR of 16.7% during the forecast years. The significant progress of this segment will be attributable to the quick turnaround time in delivering accurate results. Amongst the end users, the hospital segment is projected to hold a lion’s share in the market as the segment expands at a CAGR of 12.0% between 2015 and 2023.
Steady Rise in Infections Lead to Higher Adoption Rate of Tests
The steady rise in the incidence of Streptococcus pyogenes infection across several countries of Europe has been the very reason for the spike in the demand for the molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests. These tests help in delivering quick and accurate results, which is one the most important factors contributing towards their high adoption rate. The remarkable advancements in technology of these test kits are yet also responsible for the growth of the market. For instance, Alere, Inc. launched Alere i Strep A in Europe, which functions on the isothermal nucleic acid amplification technology. The new testing method eliminates the need of thermocyclers and thus offers rapid results. Such changes in technology have come a long way in determining an effective treatment for the patient and reduction of interpretation time.
The developments have also rendered nucleic acid testing in point-of-care-testing formats allowing them to cover a wider range of patients, who do not necessarily reach out to laboratories. Thus, the advantages of modern methods of testing over traditional testing styles such as convenience, user-friendly instruments, and quick results have led to a high uptake of such tests, especially in the developing countries of Europe.
Lack of Facilities Challenge Market Growth
Despite the strong market drivers, the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests is being stymied due to poor reimbursement policies. The market is also being challenged due to the differing criteria for the nucleic acid tests in different countries of Europe. Additionally, lack of facilities due to considerably low expenditure on healthcare is also restraining the growth of the global market.
The review is based on Transparency Market Research’s report, titled “Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015-2023.”
The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe has been segmented as follows:
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Tests Products, by Type of Technique
- Isothermal nucleic acid amplification technology (iNAT)
- Polymerase chain reaction
- Non-amplified Tests
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by End-user
- Public Health Laboratories
- Others (referenced and clinical laboratories)
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by Geography
- Northern Europe
- United Kingdom of Great Britain and Northern Ireland
- Eastern Europe
- Eastern Europe
- Czech Republic
- Russian Federation
- Rest of Eastern Europe
- Western Europe
- Rest of Western Europe
- Southern Europe
- Rest of Southern Europe
- Rest of Europe (including Scandinavia, Mediterranean Europe, and Azerbaijan)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453